40 results
8-K
EX-99.1
fl4dhgj
19 Apr 23
Results of Operations and Financial Condition
5:07pm
8-K
6t82bl 6ks
19 Apr 23
Results of Operations and Financial Condition
5:07pm
8-K
EX-99.1
k4pvdrk7o 031hcvj
2 Nov 22
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
4:14pm
8-K
EX-99.1
n5j6lyq2fcmaxss
3 Aug 22
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance
4:18pm
8-K
EX-99.1
jm2fv esxjn3twy8e
4 May 22
Nevro Reports First Quarter 2022 Financial Results, Provides Second Quarter 2022 Guidance and Reiterates Full-Year 2022 Guidance
4:18pm
8-K
EX-99.1
ejsq9cp
23 Feb 22
Nevro Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides First Quarter and Full-Year 2022 Guidance
12:00am
8-K
EX-99.1
d666x5pmrm7pahr9zcp2
10 Jan 22
Nevro Announces Preliminary, Unaudited Fourth Quarter and Fourth Quarter 2021 Worldwide Revenue of Approximately $102.5 Million
6:12am
8-K
EX-99.1
ji6m 9af99lutsl9mx5t
8 Nov 21
Nevro Reports Third Quarter 2021 Financial Results and Provides Fourth Quarter Guidance
4:18pm